77014-9LOINC 2.82
Fetal Trisomy 21 risk [Interpretation] based on Plasma cell-free DNA by Sequencing Qualitative
Fet Ts 21 risk Plas.cfDNA Ql
Definition
- This term was created for, but is not limited in use to, Sequenom Laboratories' VisibiliT Trisomy 21 test, which analyzes circulating cell-free DNA extracted from maternal plasma using whole genome sequencing to determine the risk for fetal chromosome 21 aneuploidy. VisibiliT is indicated for use in pregnant women with average risk for fetal chromosomal aneuploidy.
Component
- Fetal trisomy 21 risk
Specimen / system
- Plas.cfDNA
Class
- MOLPATH.TRISOMY
Property
- Imp
Scale
- Ord
Method
- Sequencing
Related names
- Down syndrome; Downs; Down's syndrome; ds; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Impression; Impression/interpretation of study; Impressions; Inherited; Interp; Interpretation; Molecular pathology; MOLPATH; MOLPATH.TRISOMY; Next generation sequencing; NGS; Ordinal; Pl; Plasma; Plsm; Point in time; QL; Qual; Qualitative; Random; Screen; Ts; Ts 21 risk
Index terms
- Down syndrome
- Down's syndrome
- Downs
- ds
- Genetics
- Heredity
- Heritable
- high-throughput sequencing
- HTS
- Impression
- Impression/interpretation of study
- Impressions
- Inherited
- Interp
- Interpretation
- Molecular pathology
- MOLPATH
- MOLPATH.TRISOMY
- Next generation sequencing
- NGS
- Ordinal
- Pl
- Plasma
- Plsm
- Point in time
- QL
- Qual
- Qualitative
- Random
- Screen
- Ts
- Ts 21 risk